SeaStar Medical Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
12
- Stock Symbol
-
ICU
- Investments
-
2
- Share Price
-
$1.25
- (As of Thursday Closing)
SeaStar Medical General Information
Description
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Contact Information
Website
www.seastarmedical.comCorporate Office
- 3513 Brighton Boulevard
- Suite 410
- Denver, CO 80216
- United States
Corporate Office
- 3513 Brighton Boulevard
- Suite 410
- Denver, CO 80216
- United States
SeaStar Medical Timeline
SeaStar Medical Stock Performance
As of 17-Apr-2025, SeaStar Medical’s stock price is $1.25. Its current market cap is $10.9M with 8.72M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.25 | $1.28 | $1.11 - $16.00 | $10.9M | 8.72M | 400K | -$6.63 |
SeaStar Medical Financials Summary
As of 31-Dec-2024, SeaStar Medical has a trailing 12-month revenue of $135K.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 6,577 | 6,577 | 29,754 | 129,302 |
| Revenue | 135 | 135 | 0 | 0 |
| EBITDA | (24,684) | (24,684) | (25,151) | (11,559) |
| Net Income | (24,830) | (24,830) | (26,232) | (12,190) |
| Total Assets | 4,658 | 4,658 | 3,513 | 3,038 |
| Total Debt | 574 | 574 | 9,081 | 8,830 |
SeaStar Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SeaStar Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
SeaStar Medical Comparisons
Industry
Financing
Details
SeaStar Medical Competitors (5)
One of SeaStar Medical’s 5 competitors is Vapotherm, a Private Equity-Backed company based in Exeter, NH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vapotherm | Private Equity-Backed | Exeter, NH | ||||
| enVVeno Medical | Formerly PE-Backed | Irvine, CA | ||||
| IceCure Medical | Corporate Backed or Acquired | Caesarea, Israel | ||||
| NxStage Medical | Formerly VC-backed | Lawrence, MA | ||||
| Lucid Diagnostics | Corporation | New York, NY |
SeaStar Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SeaStar Medical Patents
SeaStar Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230149613-A1 | Devices and methods for treating or preventing cytokine release syndrome and tumor lysis syndrome | Pending | 29-Jun-2020 | ||
| US-20230036583-A1 | Devices and methods for reducing rejection of a transplanted organ in a recipient | Pending | 31-Dec-2019 | ||
| US-20220273855-A1 | Device and method for preparing a donor organ for transplantation | Inactive | 01-Aug-2019 | ||
| US-20150246169-A1 | Cartridge and method for increasing myocardial function | Inactive | 09-Jan-2012 | ||
| AU-2018223003-B2 | Cartridge and method for increasing myocardial function | Active | 09-Jan-2012 | A61M1/3472 |
SeaStar Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SeaStar Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SeaStar Medical Acquisitions (2)
SeaStar Medical’s most recent deal was a Merger/Acquisition with LMF Acquisition Opportunities. The deal was made on 28-Oct-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LMF Acquisition Opportunities | 28-Oct-2022 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Immunocept | 12-Jul-2018 | Merger/Acquisition | Therapeutic Devices |
SeaStar Medical FAQs
-
When was SeaStar Medical founded?
SeaStar Medical was founded in 1994.
-
Where is SeaStar Medical headquartered?
SeaStar Medical is headquartered in Denver, CO.
-
What is the size of SeaStar Medical?
SeaStar Medical has 12 total employees.
-
What industry is SeaStar Medical in?
SeaStar Medical’s primary industry is Therapeutic Devices.
-
Is SeaStar Medical a private or public company?
SeaStar Medical is a Public company.
-
What is SeaStar Medical’s stock symbol?
The ticker symbol for SeaStar Medical is ICU.
-
What is the current stock price of SeaStar Medical?
As of 17-Apr-2025 the stock price of SeaStar Medical is $1.25.
-
What is the current market cap of SeaStar Medical?
The current market capitalization of SeaStar Medical is $10.9M.
-
What is SeaStar Medical’s current revenue?
The trailing twelve month revenue for SeaStar Medical is $135K.
-
Who are SeaStar Medical’s competitors?
Vapotherm, enVVeno Medical, IceCure Medical, NxStage Medical, and Lucid Diagnostics are competitors of SeaStar Medical.
-
What is SeaStar Medical’s annual earnings per share (EPS)?
SeaStar Medical’s EPS for 12 months was -$6.63.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
